SEC Form 4/A · accession 0001225208-16-031781
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Eric Mark Green
Officer — Chief Executive Officer · Director
Period of report
Apr 24, 2015
Accepted (ET)
Apr 26, 2016 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 24, 2015 | A | 30,499 | $0.00 | A | 30,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F3 | $57.38 | Apr 24, 2015 | A | 79,816 | A | Feb 23, 2016 | Apr 24, 2025 | Common Stock | 79,816 | 79,816 | D |
| Stock Option (Right to Buy)F2,F4 | $57.38 | Apr 24, 2015 | A | 53,996 | A | Apr 24, 2015 | Apr 24, 2025 | Common Stock | 53,996 | 53,996 | D |
| Stock Option (Right to Buy)F1 | $57.38 | Apr 24, 2015 | A | 164,320 | A | Apr 24, 2018 | Apr 24, 2020 | Common Stock | 164,320 | 164,320 | D |
Explanation of responses
- F1This award vests in 2 installments beginning on 4/24/2018.
- F2Late filing due to administrative error.
- F3This award vests in 4 equal annual installments beginning on 2/23/2016.
- F4This award is 25% vested upon grant and an additional 25% vests on 2/24/16, 2/24/17 and 2/24/18.